Distinct Innate Immune Responses Following Inoculation With a Replicon mRNA COVID-19 Vaccine

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Innate immune responses are crucial for initiating adaptive immunity via cytokine signaling.
• Cytokine production profiles significantly influence vaccine efficacy and immune memory development.

Purpose of the Study:

• To compare the cytokine production patterns induced by a novel replicon mRNA COVID-19 vaccine versus conventional mRNA vaccines in a mouse model.
• To investigate the impact of replicon mRNA technology on the kinetics and duration of immune responses, specifically interferon-gamma (IFN-γ) production.

Main Methods:

• Mice were inoculated with either a novel replicon mRNA vaccine or a conventional mRNA vaccine against COVID-19.
• Quantification of cytokine production, particularly IFN-γ, was performed at various time points post-inoculation.
• Comparative analysis of immune response kinetics between the two vaccine types.

Main Results:

• The replicon mRNA vaccine elicited a biphasic and prolonged IFN-γ production after the first dose.
• Sustained IFN-γ production was observed after the second dose of the replicon mRNA vaccine.
• Conventional mRNA vaccines induced only a transient peak of IFN-γ on Day 1 post-inoculation for both doses.

Conclusions:

• Replicon mRNA vaccine technology drives a distinct and more sustained IFN-γ immune response compared to conventional mRNA vaccines.
• The self-replicating nature of the replicon mRNA may underlie the prolonged cytokine production observed.
• These findings suggest potential advantages of replicon mRNA vaccines in eliciting robust and durable adaptive immunity.